Examples of such metabolic by-products are amyloid-β (Aβ) and tau, which are found deposited in brain of subjects with neurodegenerative diseases, the most prevalent being Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.